In the 579 patients with a PSMA positive primary tumour, the observer-average sensitivity and specificity of PSMA PET/CT-based miT-stage for predicting pT3a-stage, as assessed in the radical prostatectomy specimen, were 58% and 59%, respectively. This evidence concerns the gene FOLH1 and neoplasm.